Form 4: Enfusion Director Jan Hauser Acquires 13,470 Shares of Class A Common Stock

Director Jan Hauser acquired 13,470 shares of Enfusion, Inc. Class A Common Stock on June 13, 2024, through the vesting of restricted stock units.

Summary

• On June 13, 2024, Jan Hauser, a director of Enfusion, Inc., acquired 13,470 shares of Class A Common Stock.
• The acquisition was a result of restricted stock units (RSUs) vesting under the Enfusion, Inc. 2021 Stock Option and Incentive Plan.
• The RSUs will vest fully on the earlier of June 13, 2025, or the date of the 2025 annual meeting of stockholders.
• Following the transaction, Hauser directly owns 57,925 shares of Enfusion's Class A Common Stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock acquisition through vesting of RSUs. It doesn't inherently indicate positive or negative performance, but rather a routine part of executive compensation.

Positives

• The acquisition of shares by a director could be seen as a positive signal, indicating confidence in the company's future prospects.

Future Outlook

The RSUs will vest fully on the earlier of June 13, 2025, or the date of the 2025 annual meeting of stockholders.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.

Stakeholder Impact

• The transaction may have a minor positive impact on shareholder sentiment, as it indicates a director's continued investment in the company.

Key Dates